Teva Pharmaceutical Industries (TEVA) Long-Term Debt Issuances (2017 - 2025)

Teva Pharmaceutical Industries' Long-Term Debt Issuances history runs 4 years deep, the most recent figure standing at $2.3 billion for Q2 2025.

• Quarterly Long-Term Debt Issuances changed N/A year-over-year to $2.3 billion in Q2 2025, while the trailing twelve-month figure through Mar 2026 was $3.7 billion (up 168.49% YoY) and the FY2025 annual result came in at $2.3 billion, changed N/A from the prior year.
• Long-Term Debt Issuances was $2.3 billion for Q2 2025 at Teva Pharmaceutical Industries, up from $1.4 billion in the prior quarter.
• Across five years, Long-Term Debt Issuances topped out at $2.5 billion in Q1 2023 and bottomed at $1.4 billion in Q1 2025.